ENDURANT CAPITAL MANAGEMENT LP – Ocular Therapeutix, Inc. Transaction History
ENDURANT CAPITAL MANAGEMENT LP portfolio value:
$4.41M
portfolio value
ENDURANT CAPITAL MANAGEMENT LP quarter portfolio value change:
+3.23%
quarter
Ocular Therapeutix, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +40.00% | 304.06K shares | 1.36M | $4.15 | 1.06M |
| Q2 2022 | share | Decrease | -17.72% | -163.73K shares | -1.51M | $4.02 | 760.22K |
| Q1 2022 | share | Increase | +28.84% | 206.82K shares | -424K | $4.95 | 923.96K |
| Q4 2021 | share | Increase | +17.49% | 106.74K shares | -1.10M | $6.95 | 717.14K |
| Q3 2021 | share | Increase | +6.91% | 39.43K shares | -1.99M | $10 | 610.40K |
| Q2 2021 | share | Increase | +30.08% | 132.03K shares | 893K | $14.18 | 570.97K |
| Q1 2021 | share | Increase | +51.11% | 148.46K shares | 1.19M | $16.41 | 438.93K |
| Q4 2020 | share | Decrease | -65.30% | -546.67K shares | -358K | $20.7 | 290.46K |
| Q3 2020 | share | Increase | +10.83% | 81.80K shares | 79K | $7.61 | 837.13K |
| Q2 2020 | share | Increase | 0.00% | 755.33K shares | 6.29M | $8.33 | 755.33K |
| Q2 2019 | share | Decrease | -100.00% | -716.12K shares | -2.84M | $4.4 | 0 |
| Q1 2019 | share | Increase | +207.71% | 483.39K shares | 1.91M | $3.97 | 716.12K |
| Q4 2018 | share | Decrease | -22.98% | -69.42K shares | -1.15M | $3.98 | 232.72K |
| Q3 2018 | share | Increase | +111.63% | 159.37K shares | 1.11M | $6.88 | 302.15K |
| Q2 2018 | share | Decrease | -20.00% | -35.68K shares | -198K | $6.75 | 142.77K |
| Q1 2018 | share | Increase | 0.00% | 178.46K shares | 1.16M | $6.51 | 178.46K |